相关实验视频

Updated: Jul 6, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

辅助放射治疗和化疗对胸腺瘤的影响

J Dumont¹, J Bou-Gharios², A Keller³

¹Chest Diseases Department, Hôpital Hautepierre, hôpitaux universitaires de Strasbourg, 1, place de l'Hôpital, 67000 Strasbourg, France.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

|January 5, 2024

概括

这项研究表明,在手术中添加放射治疗和化疗可以改善胸腺瘤患者的局部控制. 对复发性胸腺瘤的积极治疗方法也会带来有利的结果.

科学领域:

在瘤学瘤学.
胸部外科手术胸部外科手术
辐射瘤学辐射瘤学

背景情况:

胸腺瘤是一种罕见的胸部恶性瘤.
手术切除是胸腺瘤的主要治疗方法.
讨论了放射治疗和化疗在胸腺瘤治疗中的作用.

研究的目的:

评估辅助放射治疗和化疗在胸腺瘤治疗中的有效性.
分析影响瘤患者局部控制和整体存活率的因素.
评估患有复发性胸腺瘤的患者的结局.

主要方法:

一项单一的观察性研究包括了31名在2004年6月至2020年7月期间接受治疗的胸腺瘤患者.
分析了患者的结果,包括局部区域无复发存活率和整体存活率.
进行统计分析以确定影响治疗疗效的因素.

主要成果:

2年和5年的局部区域无复发生存率分别为96.3%和68.0%.
放射治疗和化疗显著改善了局部瘤控制 (P=0.0008和P=0.04).
较大的初始瘤大小与较差的局部控制相关 (P=0.04). 五年和十年的整体生存率分别为87.1%和81.7%. 总体生存时间的中位数没有达到. 在复发患者中,复发后的平均整体存活时间为115个月.

结论:

辅助放射治疗和化疗,除了手术,是有效的实现局部控制在胸腺瘤.
对复发性胸腺瘤患者的积极治疗策略导致了有利的结果.
这些发现支持多模式治疗胸腺瘤的方法,特别是在复发的情况下.

关键词:

化疗化疗是一种化学疗法.化学疗法是一种化学疗法.地方控制局 (Contrôle local) 在当地进行控制.当地控制局部控制地方区域无复发生存率总体生存率总体生存率患者的治疗结果.放射治疗疗法放射治疗疗法放射疗法 (Radiotherapy) 是一种放射疗法.切割外科手术 (Résection chirurgicale) 是一个手术.手术切除手术切除的方法全球调查全球调查胸腺瘤是什么意思胸腺瘤是什么意思蒂莫姆 (Thymome) 是一个长体.

更多相关视频

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...